Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - NANOSPHERE INC | c05318e8vk.htm |
| EX-10.1 - EXHIBIT 10.1 - NANOSPHERE INC | c05318exv10w1.htm |
Exhibit 99.1
Nanosphere, Inc.
4088 Commercial Avenue
Northbrook, IL 60062
4088 Commercial Avenue
Northbrook, IL 60062
Nanosphere acquires the rights to intellectual properties
NORTHBROOK, Ill., August 24, 2010 — Eppendorf AG and Nanosphere, Inc. announced today that
Nanosphere has acquired certain patents and patent rights of Eppendorf on a global basis for $4
million, while providing a limited license back to service existing Eppendorf customers and
licenses previously issued that relate to the purchased patents and patent rights. As part of the
transaction, the companies settled a patent litigation dispute.
About Nanosphere
Nanosphere, Inc. develops, manufactures and markets an advanced molecular diagnostics platform, the
Verigene® System, for direct genomic and ultra-sensitive protein detection. This easy to use and
cost effective platform enables simple, low cost and highly sensitive genomic and protein testing
on a single platform. Nanosphere is based in Northbrook, IL. Additional information is available
at: http://www.nanosphere.us.
Eppendorf AG
Eppendorf
AG, based in Hamburg, Germany, develops, produces and distributes
instruments and consumables for the Life Science research industry.
Its subsidiary, Eppendorf Array Technologies SA (EAT) specializes in biochip solutions
for various applications, GMO detection in food and feed, transcription factor profiling, and
molecular diagnostics. Additional information is available at: http://www.eppendorf.com
Contact:
Investors:
Nanosphere, Inc.
Roger Moody, 847-400-9021
rmoody@nanosphere.us
Nanosphere, Inc.
Roger Moody, 847-400-9021
rmoody@nanosphere.us
or
Media
The Torrenzano Group
Ed Orgon, 212-681-1700
ed@torrenzano.com
The Torrenzano Group
Ed Orgon, 212-681-1700
ed@torrenzano.com